Emerging role of exosomal-microRNA in obesity

Achala Theres P Moncy1,2, Samarjit Das2, Hannah R Vasanthi1

  • 1Department of Biotechnology, Pondicherry University, Puducherry, India.

Insights

Exosomes, tiny vesicles carrying microRNAs (miRNAs), are crucial in cell communication and obesity. These exosomal miRNAs show promise as early diagnostic biomarkers and therapeutic targets for obesity and related conditions.

Area of Science:

  • Cell biology
  • Biochemistry
  • Metabolic diseases

Background:

  • Exosomes are extracellular vesicles involved in intercellular communication.
  • Exosomal microRNAs (miRNAs) are implicated in various pathophysiological processes.
  • Obesity involves complex mechanisms, including cellular signaling pathways.

Purpose of the Study:

  • To review the role of exosomal miRNAs in obesity.
  • To highlight exosomal miRNAs as potential diagnostic biomarkers.
  • To discuss exosomal miRNAs as therapeutic targets for obesity.

Main Methods:

  • Literature review of recent studies on exosomal miRNAs and obesity.
  • Analysis of the role of exosomal cargo, specifically miRNAs, in obesity pathogenesis.
  • Evaluation of the diagnostic and therapeutic potential of exosomal miRNAs.

Main Results:

  • Exosomal miRNAs play a significant role in obesity progression.
  • These miRNAs are involved in obesity-associated pathophysiological conditions.
  • Exosomal miRNAs are identified as key players in metabolic dysregulation.

Conclusions:

  • Exosomal miRNAs are critical in understanding obesity.
  • They represent promising early diagnostic biomarkers for obesity.
  • Exosomal miRNAs offer potential therapeutic strategies for obesity management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...